MYLAN, LDA. secures contract for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/491 - Oncological Medicines And Immunomodulators); 2023/495 - Medicines

Portugal, Dec. 3 -- Portugal based MYLAN, LDA. has secured contract from Unidade Local De Saude Do Alentejo Central, E. P. E. for Call For Proposals Under Framework Agreement(S) 2023/304 - Group 4 Medicines: Blood; 2023/491 - Oncological Medicines And Immunomodulators); 2023/495 - Medicines. The value of the contract is worth 2090000 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....